Your session is about to expire
← Back to Search
Other
Photodynamic Therapy vs Chemical Peels for Actinic Keratosis
Phase 2
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
>18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-8 weeks after treatments
Awards & highlights
Study Summary
This trial is comparing photodynamic therapy to a combination of Jessner's solution and 35% TCA chemical peels to see which is more effective for treating actinic keratoses.
Who is the study for?
This trial is for adults over 18 in the Chicago area who want to treat actinic keratoses on both upper arms and are in good health. They must understand and sign a consent form. Pregnant or nursing individuals, those with communication issues, or extensive skin conditions like eczema or psoriasis on their arms cannot participate.Check my eligibility
What is being tested?
The study compares two treatments for actinic keratosis: photodynamic therapy (PDT) on one arm versus a chemical peel using Jessner's solution and trichloroacetic acid (TCA) on the other arm. Each participant receives both treatments, one on each arm, to see which works better.See study design
What are the potential side effects?
Potential side effects of PDT may include redness, swelling, and discomfort at the treatment site. Chemical peels might cause stinging, redness, peeling, scabbing or changes in skin color.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-8 weeks after treatments
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-8 weeks after treatments
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of total AKs cleared
Trial Design
2Treatment groups
Active Control
Group I: Chemical PeelsActive Control1 Intervention
One upper arm will be exposed to Jessner's Solution AND 35% Trichloroacetic acid peel
Group II: Photodynamic TherapyActive Control1 Intervention
One upper arm will be exposed to blue light therapy
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
917,191 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,520 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have severe skin conditions on your arms that would make it hard for you to receive treatment.I can communicate and cooperate with my doctor without issues.I am older than 18 years.I want treatment for skin lesions on both of my upper arms.
Research Study Groups:
This trial has the following groups:- Group 1: Chemical Peels
- Group 2: Photodynamic Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research still recruiting new participants?
"According to records on clinicaltrials.gov, this medical study is no longer recruiting participants. The trial was uploaded on the 1st of January 2023 and the last update happened on March 2nd 2022. Despite that, current information indicates there are 20 other ongoing trials which are seeking patients right now."
Answered by AI
What adverse effects could occur from Photodynamic Therapy?
"After evaluating the available clinical data, our team at Power assigned Photodynamic Therapy a score of 2 on a scale from 1 to 3 due to its Phase 2 trial status. This implies that there is evidence confirming safety but no efficacy reports yet."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger